173 related articles for article (PubMed ID: 25129317)
1. Mutant prevention concentrations of pradofloxacin for susceptible and mutant strains of Escherichia coli with reduced fluoroquinolone susceptibility.
Marcusson LL; Komp Lindgren P; Olofsson SK; Hughes D; Cars O
Int J Antimicrob Agents; 2014 Oct; 44(4):354-7. PubMed ID: 25129317
[TBL] [Abstract][Full Text] [Related]
2. Dose-related selection of fluoroquinolone-resistant Escherichia coli.
Olofsson SK; Marcusson LL; Strömbäck A; Hughes D; Cars O
J Antimicrob Chemother; 2007 Oct; 60(4):795-801. PubMed ID: 17635875
[TBL] [Abstract][Full Text] [Related]
3. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
[TBL] [Abstract][Full Text] [Related]
4. Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.
Gebru E; Choi MJ; Lee SJ; Damte D; Park SC
J Med Microbiol; 2011 Oct; 60(Pt 10):1512-1522. PubMed ID: 21596912
[TBL] [Abstract][Full Text] [Related]
5. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
Pasquali F; Manfreda G
Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
[TBL] [Abstract][Full Text] [Related]
6. Mutant prevention concentration and phenotypic and molecular basis of fluoroquinolone resistance in clinical isolates and in vitro-selected mutants of Escherichia coli from dogs.
Gebru E; Damte D; Choi MJ; Lee SJ; Kim YH; Park SC
Vet Microbiol; 2012 Jan; 154(3-4):384-94. PubMed ID: 21893387
[TBL] [Abstract][Full Text] [Related]
7. Predicting bacterial resistance using the time inside the mutant selection window: possibilities and limitations.
Firsov AA; Portnoy YA; Strukova EN; Shlykova DS; Zinner SH
Int J Antimicrob Agents; 2014 Oct; 44(4):301-5. PubMed ID: 25218155
[TBL] [Abstract][Full Text] [Related]
8. Tuning of antibacterial activity of a cyclopropyl fluoroquinolone by variation of the substituent at position C-8.
Wetzstein HG; Hallenbach W
J Antimicrob Chemother; 2011 Dec; 66(12):2801-8. PubMed ID: 21948964
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the minimum inhibitory, mutant prevention and minimum bactericidal concentrations of ciprofloxacin, levofloxacin and garenoxacin against enteric Gram-negative urinary tract infection pathogens.
Hansen GT; Blondeau JM
J Chemother; 2005 Oct; 17(5):484-92. PubMed ID: 16323436
[TBL] [Abstract][Full Text] [Related]
10. In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.
Croisier D; Etienne M; Piroth L; Bergoin E; Lequeu C; Portier H; Chavanet P
J Antimicrob Chemother; 2004 Sep; 54(3):640-7. PubMed ID: 15317743
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of several fluoroquinolones and beta-lactams in terms of their capability to restrict the selection of fluoroquinolone-resistant Salmonella: in vitro models.
Cebríán L; Rodríguez JC; Escribiano I; Royo SG
APMIS; 2007 Dec; 115(12):1376-82. PubMed ID: 18184408
[TBL] [Abstract][Full Text] [Related]
12. Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin.
Ferran A; Dupouy V; Toutain PL; Bousquet-Mélou A
Antimicrob Agents Chemother; 2007 Nov; 51(11):4163-6. PubMed ID: 17709467
[TBL] [Abstract][Full Text] [Related]
13. In vitro selection of resistance to pradofloxacin and ciprofloxacin in canine uropathogenic Escherichia coli isolates.
Liu X; Lazzaroni C; Aly SA; Thungrat K; Boothe DM
Vet Microbiol; 2014 Dec; 174(3-4):514-522. PubMed ID: 25465666
[TBL] [Abstract][Full Text] [Related]
14. Comparative mutant prevention concentrations of pradofloxacin and other veterinary fluoroquinolones indicate differing potentials in preventing selection of resistance.
Wetzstein HG
Antimicrob Agents Chemother; 2005 Oct; 49(10):4166-73. PubMed ID: 16189094
[TBL] [Abstract][Full Text] [Related]
15. Predictors of bacterial resistance using in vitro dynamic models: area under the concentration-time curve related to either the minimum inhibitory or mutant prevention antibiotic concentration.
Strukova EN; Portnoy YA; Zinner SH; Firsov AA
J Antimicrob Chemother; 2016 Mar; 71(3):678-84. PubMed ID: 26626718
[TBL] [Abstract][Full Text] [Related]
16. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
Li Q; Bi X; Diao Y; Deng X
Am J Vet Res; 2007 Aug; 68(8):812-5. PubMed ID: 17669019
[TBL] [Abstract][Full Text] [Related]
17. Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.
Jakobsen L; Cattoir V; Jensen KS; Hammerum AM; Nordmann P; Frimodt-Møller N
J Antimicrob Chemother; 2012 Oct; 67(10):2438-44. PubMed ID: 22685162
[TBL] [Abstract][Full Text] [Related]
18. Comparative mutant prevention concentration and mechanism of resistance to veterinary fluoroquinolones in Staphylococcus pseudintermedius.
Awji EG; Tassew DD; Lee JS; Lee SJ; Choi MJ; Reza MA; Rhee MH; Kim TH; Park SC
Vet Dermatol; 2012 Aug; 23(4):376-80, e68-9. PubMed ID: 22409306
[TBL] [Abstract][Full Text] [Related]
19. Relationships between mutant prevention concentrations and mutation frequencies against enrofloxacin for avian pathogenic Escherichia coli isolates.
Ozawa M; Asai T
J Vet Med Sci; 2013; 75(6):709-13. PubMed ID: 23328636
[TBL] [Abstract][Full Text] [Related]
20. [Resistant mutant prevention concentration of fluoroquinolones in clinical isolates of extended spectrum beta-lactamase (ESBL) producing and non-producing strains of Escherichia coli].
Noguera O; Rodríguez JC; López JM; Ruiz M; Royo G
Rev Esp Quimioter; 2009 Mar; 22(1):30-3. PubMed ID: 19308744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
